396 related articles for article (PubMed ID: 28253990)
21. Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso SM; Correia SC; Carvalho C; Moreira PI
Handb Exp Pharmacol; 2017; 240():281-308. PubMed ID: 28251365
[TBL] [Abstract][Full Text] [Related]
22. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
24. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
Pugazhenthi S; Qin L; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
[TBL] [Abstract][Full Text] [Related]
25. Synaptic mitochondrial pathology in Alzheimer's disease.
Du H; Guo L; Yan SS
Antioxid Redox Signal; 2012 Jun; 16(12):1467-75. PubMed ID: 21942330
[TBL] [Abstract][Full Text] [Related]
26. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.
Lourenco MV; Ferreira ST; De Felice FG
Prog Neurobiol; 2015 Jun; 129():37-57. PubMed ID: 25857551
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's pathogenesis and its link to the mitochondrion.
Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
Grimm A; Friedland K; Eckert A
Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.
Omori C; Motodate R; Shiraki Y; Chiba K; Sobu Y; Kimura A; Nakaya T; Kondo H; Kurumiya S; Tanaka T; Yamamoto K; Nakajima M; Suzuki T; Hata S
Nutr Neurosci; 2017 Nov; 20(9):538-546. PubMed ID: 27329428
[TBL] [Abstract][Full Text] [Related]
31. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
[TBL] [Abstract][Full Text] [Related]
32. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
34. Multiple defects in energy metabolism in Alzheimer's disease.
Ferreira IL; Resende R; Ferreiro E; Rego AC; Pereira CF
Curr Drug Targets; 2010 Oct; 11(10):1193-206. PubMed ID: 20840064
[TBL] [Abstract][Full Text] [Related]
35. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease.
Pereira C; Ferreiro E; Cardoso SM; de Oliveira CR
J Mol Neurosci; 2004; 23(1-2):97-104. PubMed ID: 15126695
[TBL] [Abstract][Full Text] [Related]
36. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
Moreira PI; Santos MS; Seiça R; Oliveira CR
J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.
Amorim JA; Canas PM; Tomé AR; Rolo AP; Agostinho P; Palmeira CM; Cunha RA
J Alzheimers Dis; 2017; 60(2):525-536. PubMed ID: 28869472
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial alterations in Alzheimer's disease.
Baloyannis SJ
J Alzheimers Dis; 2006 Jul; 9(2):119-26. PubMed ID: 16873959
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria in aging and Alzheimer's disease.
Crouch PJ; Cimdins K; Duce JA; Bush AI; Trounce IA
Rejuvenation Res; 2007 Sep; 10(3):349-57. PubMed ID: 17708691
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
Reddy AP; Reddy PH
Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
